References

Temporal trends of inflammatory bowel disease burden in China from 1990 to 2030 with comparisons to Japan, South Korea, the European Union, the United States of America, and the world

10.2147/clep.s402718 · 2023 · External reference

Epidemiological research, burden, and clinical advances of inflammatory bowel disease in China

10.1097/cm9.0000000000003064 · 2024 · External reference

Ulcerative colitis

10.1016/s0140-6736(23)00966-2 · 2023 · External reference

The microbiome and inflammatory bowel disease

10.1016/j.jaci.2019.11.003 · 2020 · External reference

Inflammatory bowel disease: pathogenesis

10.3748/wjg.v20.i1.91 · 2014 · External reference

Navigating the intersection: sarcopenia and Sarcopenic obesity in inflammatory bowel disease

10.3390/biomedicines12061218 · 2024 · External reference

The influence of cytokines on the complex pathology of ulcerative colitis

10.1016/j.autrev.2021.103017 · 2022 · External reference

The molecular basis of sarcopenia in inflammatory bowel disease: from gut-muscle axis to therapeutic opportunities

10.23736/s2724-5985.25.03967-1 · 2025 · External reference

Systematic review of sarcopenia in inflammatory bowel disease

10.1016/j.clnu.2023.05.002 · 2023 · External reference

Sarcopenia is common in ulcerative colitis and correlates with disease activity

10.5217/ir.2023.00090 · 2024 · External reference

Sarcopenia and treatment failure in inflammatory bowel disease: a systematic review and meta-analysis

10.17235/reed.2023.9808/2023 · 2024 · External reference

The importance of sarcopenia as a prognostic predictor of the clinical course in acute severe ulcerative colitis patients

10.1016/j.dld.2021.03.031 · 2021 · External reference

Aging gut microbiota at the cross-road between nutrition, physical frailty, and sarcopenia: is there a gut-muscle axis?

10.3390/nu9121303 · 2017 · External reference

Gut microbiome mediates the effect of inflammatory bowel disease on sarcopenia: a bidirectional Mendelian randomization study

10.1159/000549749 · 2025 · External reference

Shared molecular features and potential diagnostic biomarkers between ulcerative colitis and sarcopenia: an integrative bioinformatics analysis with preliminary experimental validation

10.3389/fimmu.2026.1801914 · 2026 · External reference

Gut microbial, inflammatory and metabolic signatures in older people with physical frailty and sarcopenia: results from the BIOSPHERE study

10.3390/nu12010065 · 2020 · External reference

Probiotic administration increases amino acid absorption from plant protein: a placebo-controlled, randomized, double-blind, multicenter, crossover study

10.1007/s12602-020-09656-5 · 2020 · External reference

Altered serum short-chain fatty acids in sarcopenia among Chinese elderly women: a case-control study

10.1186/s12877-025-06564-7 · 2025 · External reference

Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders

10.1093/ecco-jcc/jjx008 · 2017 · External reference

A focus shift from sarcopenia to muscle health in the Asian working Group for Sarcopenia 2025 consensus update

10.1038/s43587-025-01004-y · 2025 · External reference

Myopenia and body fat distribution in hospitalized ulcerative colitis patients: correlations with clinical characteristics and response to vedolizumab

10.3389/fnut.2024.1411695 · 2024 · External reference

Asian working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment

10.1016/j.jamda.2019.12.012 · 2020 · External reference

A weakly informative default prior distribution for logistic and other regression models

10.1214/08-aoas191 · 2008 · External reference

Sparse data bias: a problem hiding in plain sight

10.1136/bmj.i1981 · 2016 · External reference

CT-assessed sarcopenia is a predictive factor for both long-term and short-term outcomes in gastrointestinal oncology patients: a systematic review and meta-analysis

10.1186/s40644-019-0270-0 · 2019 · External reference

Impact of malnutrition and sarcopenia on quality of life in patients with inflammatory bowel disease: a multicentre study

10.1002/jcsm.13341 · 2023 · External reference

Soluble intercellular adhesion molecule-1, D-lactate and diamine oxidase in patients with inflammatory bowel disease

10.3748/wjg.15.3916 · 2009 · External reference

Diagnostic and clinical significance of serum levels of D-lactate and diamine oxidase in patients with Crohn’s disease

10.1155/2019/8536952 · 2019 · External reference

Gut microbiota contribute to age-related changes in skeletal muscle size, composition, and function: biological basis for a gut-muscle axis

10.1007/s00223-017-0345-5 · 2018 · External reference

A narrative review of gut-muscle Axis and sarcopenia: the potential role of gut microbiota

10.2147/ijgm.s301141 · 2021 · External reference

The conjugated bile acids profile suggests a novel liver-muscle axis associated with sarcopenia in chronic liver disease

10.1111/liv.70612 · 2026 · External reference

Bile acid metabolism dysregulation associates with cancer cachexia: roles of liver and gut microbiome

10.1002/jcsm.12798 · 2021 · External reference

Sarcopenia-related gut microbiota in the elderly: insights from the longevity region of Kyotango and its nutritional associations

10.1080/29933935.2025.2591561 · 2025 · External reference

Association of skeletal muscle function, quantity, and quality with gut microbiota in Japanese adults: a cross-sectional study

10.1111/ggi.14751 · 2024 · External reference

Microbial adaptation and host signaling: Bacteroides-bile acid interactions in gut health

10.1016/j.anaerobe.2026.103041 · 2026 · External reference

Interplay between bile acids and intestinal microbiota: regulatory mechanisms and therapeutic potential for infections

10.3390/pathogens13080702 · 2024 · External reference

Screening of lactic acid bacteria for bile salt hydrolase activity

10.3168/jds.s0022-0302(99)75506-2 · 1999 · External reference

Metabolomic analysis in inflammatory bowel disease: a systematic review

10.1093/ecco-jcc/jjaa227 · 2021 · External reference

Biomarkers of metabolomics in inflammatory bowel disease and damp-heat syndrome: a preliminary study

10.1155/2022/3319646 · 2022 · External reference

Changes of plasma fasting carnitine ester profile in patients with ulcerative colitis

10.3748/wjg.v12.i1.110 · 2006 · External reference

Comprehensive review of the expanding roles of the carnitine pool in metabolic physiology: beyond fatty acid oxidation

10.1186/s12967-025-06341-5 · 2025 · External reference

Acylcarnitines: nomenclature, biomarkers, therapeutic potential, drug targets, and clinical trials

10.1124/pharmrev.121.000408 · 2022 · External reference

Intramuscular short-chain acylcarnitines in elderly people are decreased in (pre-)frail females, but not in males

10.1096/fj.202000493r · 2020 · External reference

Amino acid metabolism in intestinal bacteria: links between gut ecology and host health

10.2741/3820 · 2011 · External reference

A review of the relationship between the gut microbiota and amino acid metabolism

10.1007/s00726-017-2493-3 · 2017 · External reference

The role of microbial amino acid metabolism in host metabolism

10.3390/nu7042930 · 2015 · External reference

Protein supplements and their relation with nutrition, microbiota composition and health: is more protein always better for sportspeople?

10.3390/nu11040829 · 2019 · External reference

L-carnitine and acylcarnitines: mitochondrial biomarkers for precision medicine

10.3390/metabo11010051 · 2021 · External reference

Adjusting for multiple testing--when and how?

10.1016/s0895-4356(00)00314-0 · 2001 · External reference